MK-2866 (Ostarine) Capsules

€ 37,95

MK-2866 capsules, also identified as Ostarine, contain a formulated presentation of an arylpropionamide research compound offered by Raw Lab Chems with seller-specified ≥98% purity. The material is intended exclusively for controlled in-vitro, chemical, forensic, and analytical research.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-13109 Category:
Description

MK-2866 (Ostarine) Capsules

Product Overview

MK-2866 capsules, also identified as Ostarine capsules, provide a formulated presentation of MK-2866, a synthetic research compound described in the supplied information as a non-steroidal selective androgen receptor modulator (SARM). The material is positioned as an analytical reference for controlled chemical, structural, chromatographic, and comparative laboratory investigation.

Raw Lab Chems presents this material exclusively for in-vitro laboratory and analytical research. The supplied specification states ≥98% purity for a typical batch. Although the source describes this value as third-party verified, no corresponding Certificate of Analysis or independent laboratory report accompanied the supplied information. The purity specification is therefore treated as seller-provided information rather than independently verified analytical evidence.

The source discusses receptor-binding interactions, tissue-selective androgen-receptor research, structure-activity relationships, analytical detection, forensic analysis, and related biochemical assays. These subjects establish scientific research context only and are not presented as therapeutic, hormonal, muscle-building, athletic-performance, or other personal-use benefits.

Chemical Identity & Classification

The supplied systematic chemical name for MK-2866 is (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide.

The source provides CAS 841205-47-8, molecular formula C19H14F3N3O3, and molecular weight 389.33 g/mol. It describes MK-2866, also known as Ostarine, as belonging to the arylpropionamide class of selective androgen receptor modulators.

The systematic name contains a defined (2S) stereochemical designation. This information should be preserved in identity-sensitive laboratory records rather than assuming that unspecified stereochemical forms are chemically or analytically equivalent.

The supplied chemical name, CAS number, molecular formula, and molecular weight are reproduced as provided. They have not been silently corrected or reconciled against outside chemical databases.

Researchers may consult PubChem when reviewing public chemical-reference information. Any database record selected for analytical work should be checked against the exact compound identity, stereochemistry, and chemical form documented for the research sample.

Chemical & Physical Characteristics

The supplied material is described as a capsule formulation intended for controlled laboratory handling and analytical investigation. No verified capsule color, shell composition, dimensions, fill appearance, excipient profile, particle-size distribution, or other formulation-specific physical characteristics were provided.

The molecular formula C19H14F3N3O3 and molecular weight 389.33 g/mol describe the underlying MK-2866 compound according to the supplied source rather than the complete capsule formulation. Capsule-shell materials and any unspecified excipients would constitute additional components and should be considered separately during formulation-specific analytical work.

No quantitative solubility data, melting point, density, hygroscopicity, or other detailed physicochemical measurements were supplied. Such characteristics are therefore not inferred from isolated powder, other SARM-class compounds, or structurally related materials.

The supplied storage guidance specifies a cool, dry environment protected from light and recommends 2–8°C for optimal long-term stability. No supporting stability study, degradation profile, or validated shelf-life dataset accompanied the source. The temperature recommendation is therefore presented as seller-provided guidance rather than independently validated stability data.

Purity & Analytical Verification

The supplied specification for MK-2866 capsules states ≥98% purity for a typical batch of the underlying research compound.

The source characterizes this purity specification as third-party verified and states that Certificates of Analysis are available upon request. HPLC, LC-MS, and NMR spectroscopy are additionally identified as analytical techniques relevant to characterization of the material.

No batch-specific Certificate of Analysis, HPLC chromatogram, LC-MS data, NMR spectrum, or independent laboratory report accompanied the supplied information. Consequently, the purity value and third-party verification statements are treated as seller-supplied claims rather than independently established results for a particular batch.

HPLC, LC-MS, NMR, and related instrumental methods can support chemical characterization when appropriately validated for the intended analytical objective. Depending on methodology, these techniques may provide information concerning identity, purity, impurity profiles, structural characteristics, and differentiation from related research compounds.

Because this is a formulated material, chemical purity and formulation uniformity represent separate analytical characteristics. A stated purity value for the underlying compound does not independently establish the composition or uniform distribution of the complete capsule formulation.

Quality Control & Batch Integrity

Reliable analytical research requires documentation connecting experimental observations to the exact material examined. Useful laboratory records can include chemical identity, stereochemical designation, formulation type, supplier, lot or batch identifier, receipt date, storage history, analytical documentation, and chain-of-custody information where appropriate.

The supplied source describes batch-specific tracking, full documentation for traceability, independent laboratory verification of identity and purity, third-party Certificate of Analysis availability, and production under ISO-compliant conditions.

No supporting ISO certification, quality-system documentation, Certificate of Analysis, batch record, independent laboratory report, or formulation-uniformity study was supplied. These statements therefore remain source-provided quality claims rather than independently established certifications or guarantees.

Researchers conducting comparative, forensic, or longitudinal analytical studies should ensure that observations can be connected to the precise research sample examined. Differences in lots, formulations, storage history, reference standards, or analytical methods may introduce variables relevant to interpretation.

No additional third-party certification, manufacturing-standard, or lot-to-lot reproducibility guarantee is made without supporting documentation.

Safety, Handling & Laboratory Precautions

MK-2866 should be handled exclusively by appropriately trained personnel in a controlled laboratory environment. Suitable personal protective equipment, ventilation, containment, access restrictions, and waste-management procedures should be established through institutional risk assessment and applicable safety documentation.

The compound’s experimental association with androgen-receptor research should be considered when laboratories establish appropriate controls. Activity observed in biochemical or cellular experimental systems does not establish safety or suitability for human or veterinary exposure.

Researchers should consult an applicable Safety Data Sheet for the exact compound and formulation when establishing procedures concerning accidental exposure, spills, contamination control, environmental release, waste collection, and disposal.

The research material should remain secured against unauthorized access and separated from food, beverages, children, pets, and non-research environments. Laboratory procedures should also minimize unintended contamination of analytical instruments, samples, work surfaces, and waste streams.

Packaging, Labeling & Storage

The supplied information states that orders are securely packaged with labeling appropriate for chemical research materials. No packaging specification, container-closure validation, transportation study, or supporting technical documentation was provided to independently establish these characteristics.

The supplied storage recommendation specifies a cool, dry environment protected from light, with 2–8°C identified as the preferred range for long-term stability. This recommendation is retained as source-provided guidance rather than represented as independently validated Raw Lab Chems stability data.

Researchers should follow documentation applicable to the specific batch, relevant SDS guidance, and institutional chemical-storage requirements.

Because the material is supplied as a capsule formulation, laboratory records should distinguish the complete formulation from isolated MK-2866 reference material. Labels should preserve the MK-2866 and Ostarine identifiers, relevant stereochemical information, and lot or batch identifier where available. Storage history should also be documented when environmental variables could influence subsequent analytical observations.

Intended Research Use & Market Positioning

MK-2866 is positioned for controlled laboratory investigation involving chemical characterization, analytical reference work, androgen-receptor research, comparative SARM chemistry, structure-activity relationships, chromatographic detection, and analytical method development.

The supplied source specifically identifies HPLC, LC-MS, and NMR spectroscopy as relevant analytical techniques. It also describes forensic analysis, pharmaceutical impurity profiling, detection in complex matrices, and academic investigation of selective androgen receptor modulator analogues as potential research contexts.

References to androgen-receptor binding and tissue selectivity describe subjects of experimental investigation rather than established medical, physiological, bodybuilding, or performance benefits.

Researchers comparing different forms of the same named research compound can separately examine Raw Lab Chems MK-2866 Powder (Ostarine). Powder and capsule formulations should not automatically be treated as analytically interchangeable because formulation components may differ.

For comparative catalog research involving another SARM-class material, Raw Lab Chems also lists RAD-140 Powder (Testolone).

The Raw Lab Chems MK-2866 Ostarine Capsules research listing provides the catalog reference for the formulation described here.

No medical, therapeutic, diagnostic, veterinary, hormonal, bodybuilding, muscle-building, athletic-performance, or consumptive application is represented by this description.

Ordering, Availability & Fulfillment

Institutional procurement of MK-2866 should begin with confirmation of the required chemical identity, stereochemical specification, formulation, analytical documentation, institutional authorization, and jurisdiction-specific requirements applicable to the proposed research.

The supplied source describes worldwide shipping to qualified research institutions, secure packaging, chemical-research labeling, and shipment tracking. These logistics statements are not independently verified here, and no current fulfillment documentation was supplied.

No claims are therefore made concerning current inventory, package configurations, dispatch schedules, delivery times, shipping destinations, courier services, tracking availability, customs processing, geographic availability, or payment methods.

Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of the material are permitted and appropriately authorized within their jurisdiction and institutional framework.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

MK-2866 is presented as an experimental laboratory research compound. Regulatory treatment may differ according to jurisdiction, intended research activity, institutional policy, and applicable medicines, sporting, chemical-control, forensic, or research frameworks.

Researchers and institutions are responsible for determining and complying with applicable requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.

A research-use designation does not establish universal legality, medical approval, suitability as a dietary supplement, or exemption from anti-doping, medicines, chemical-control, institutional, or other applicable requirements.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “MK-2866 (Ostarine) Capsules”
Shipping & Delivery